Physicochemical characterization of phyllanthin from Phyllanthus amarus Schum. et Thonn.

References

• Rajakannan V, Sripathi MS, Selvanayagam S, et al. Phyllanthin from the plant Phyllanthus amarus. Acta Cryst 2003;E59:o203–5
   Google Scholar
• Krithika R, Mohankumar R, Verma RJ, et al. Isolation, characterization and antioxidative effect of phyllanthin against CCl4-induced toxicity in HepG2 cell line. Chem Biol Interact 2009;181:351–8
   PubMed Web of Science ®Google Scholar
• Syamasundar KV, Singh B, Thakur RS, et al. Antihepatotoxic principles of Phyllanthus niruri herbs. J Ethnopharmacol 1985;14:41–4
   PubMed Web of Science ®Google Scholar
• Chirdchupunseree H, Pramyothin P. Protective activity of phyllanthin in ethanol-treated primary culture of rat hepatocytes. J Ethnopharmacol 2010;128:172–6
   PubMed Web of Science ®Google Scholar
• Murugaiyah V, Chan K. Antihyperuricemic lignans from the leaves of Phyllanthus niruri. Planta Med 2006;72:1262–7
   PubMed Web of Science ®Google Scholar
• Murugaiyah V, Chan K. Mechanisms of antihyperuricemic effect of Phyllanthus niruri and its lignan constituents. J Ethnopharmacol 2009;124:233–9
   PubMed Web of Science ®Google Scholar
• Somanabandhu A, Nitayangkura S, Mahidol C, et al. 1H-NMR and 13C-NMR assignments of phyllanthin and hypophyllathin lignans that enhance cytotoxic responses with cultured multidrug-resistant cells. J Nat Prod 1993;5:233–9
   Web of Science ®Google Scholar
• Leite DF, Kassuya CA, Mazzuco TL, et al. The cytotoxic effect and the multidrug resistance reversing action of lignans from Phyllanthus amarus. Planta Med 2006;72:1353–8
   PubMed Web of Science ®Google Scholar
• Bahramikia S, Yazdanparast R. Phytochemistry and Medicinal Properties of Teucrium polium L. (Lamiaceae). Phytother Res 2012;26:1581–93
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007;70:461–77
   PubMed Web of Science ®Google Scholar
• Butler MS. Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep 2008;25:475–516
   PubMed Web of Science ®Google Scholar
• Harvey AL. Natural products in drug discovery. Drug Discov Today 2008;13:894--901
   PubMed Web of Science ®Google Scholar
• Wu S, Yang L, Gao Y, et al. Multi-channel counter-current chromatography for highthroughput fractionation of natural products for drug discovery. J Chromatogr A 2007;1180:99–107
   PubMed Web of Science ®Google Scholar
• Harvey AL. Natural products as a screening resource. Curr Opin Chem Biol 2007;11:480–4
   PubMed Web of Science ®Google Scholar
• Singh SB, Barrett JF. Empirical antibacterial drug discovery–foundation in natural products. Biochem Pharmacol 2006;71:1006–15
   PubMed Web of Science ®Google Scholar
• El-Gendy AM, Adejare A. Membrane permeability related physicochemical properties of a novel γ-secretase inhibitor. Int J Pharm 2004;280:47–55
   PubMed Web of Science ®Google Scholar
• Di L, Kerns EH. Profiling drug-like properties in discovery research. Curr Opin Chem Biol 2003;7:402–8
   PubMed Web of Science ®Google Scholar
• Lu D, Chambers P, Wipf P, et al. Lipophilicity screening of novel drug-like compounds and comparison to clogP. J Chromatogr A 2012;1258:161–7
   PubMed Web of Science ®Google Scholar
• Allen Jr LV. Dosage form design and development. Clin Ther 2008;30:2102–11
   PubMed Web of Science ®Google Scholar
• Huang LF, Tong WQ. Impact of solid state properties on developability assessment of drug candidates. Adv Drug Deliver Rev 2004;56:321–34
   PubMed Web of Science ®Google Scholar
• Shah AK, Wyandt CM, Stodghill SP. Physico chemical characterization of a novel anti-cancer agent and its comparison to Taxol®. Drug Dev Ind Pharm 2013;39:89–101
   PubMed Web of Science ®Google Scholar
• Murugaiyah V, Chan KL. Analysis of lignans from Phyllanthus niruri L. in plasma using a simple HPLC method with fluorescence detection and its application in a pharmacokinetic study. J Chromato B 2007;852:138–44
   PubMed Web of Science ®Google Scholar
• Mularczyk-Oliwa M, Bombalska A, Kaliszewski M, et al. Comparison of fluorescence spectroscopy and FTIR in differentiation of plant pollens. Spectrochim Acta A 2012;97:246–54
   PubMed Web of Science ®Google Scholar
• OECD Guidelines for the Testing of Chemicals, No. 107, Organization for Economic Co-operation and Development (OECD), Paris, 1995
   Google Scholar
• Garekani HA, Sadeghi F, Badiee A, et al. Crystal habit modifications of ibuprofen and their physicomechanical characteristics. Drug Dev Ind Pharm 2001;27:803–9
   PubMed Web of Science ®Google Scholar
• Morissette SL, Almarsson O, Peterson ML, et al. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. Adv Drug Del Rev 2004;56:275–300
   PubMed Web of Science ®Google Scholar
• Datta S, Grant DJW. Crystal structures of drugs: advances in determination, prediction and engineering. Nat Rev Drug Discovery 2004;3:42–57
   PubMed Web of Science ®Google Scholar
• Byrn S, Pfeiffer R, Ganey M, et al. Pharmaceutical solids: a strategic approach to regulatory considerations. Pharm Res 1995;12:945–54
   PubMed Web of Science ®Google Scholar
• Kararli TT. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos 1995;16:351–80
   PubMed Web of Science ®Google Scholar
• Saxena V, Panicucci R, Joshi Y, Garad S. Developability assessment in Pharmaceutical Industry: an integrated group approach for selecting developable candidates. J Pharm Sci 2009;98:1962–79
   PubMed Web of Science ®Google Scholar
• Loos D, Pasel C, Luckas M, et al. Experimental investigation and modelling of the solubility of calcite and gypsum in aqueous systems at higher ionic strength. Fluid Phase Equilibr 2004;219:219–29
   Web of Science ®Google Scholar
• Schulz C, Koch JD, Davidson DF, et al. Ultraviolet absorption spectra of shock-heated carbon dioxide and water between 900 and 3050 K. Chem Phys Lett 2002;355:82–8
   Web of Science ®Google Scholar
• Sangster J. Octanol–Water Partition Coefficients: Fundamentals and Physical Chemistry. New York: Wiley; 1997
   Google Scholar
• Lennarnas H, Abrahamsson B. The use of biopharmaceutical classification of drugs in drug discovery and development: current status and future extensions. J Pharm Pharmacol 2005;57:273–85
   PubMed Web of Science ®Google Scholar
• Mwatamba K, Torrado S, Bandera C, et al. The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs. Int J Pharm 2004;272:29–36
   PubMed Web of Science ®Google Scholar